Opinion Research Centre’s Post

#Precision #Medicine #Software Market Size, Share & Trends Analysis Report By Delivery Mode (On-premise, Web & Cloud-based), By Application (Oncology Pharmacogenomics, Other Applications), By End User (Healthcare Providers, Research & Government Institutes, Pharmaceutical & Biotechnology Companies), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028. 👤IMIR Market Research Pvt. Ltd.👤 📚𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐏𝐫𝐢𝐜𝐞:📝👇https://lnkd.in/dhMEs3ZP Increasing Adoption of AI and Big Data Analytics: The growth of AI and big data technologies has led to more sophisticated tools that can process large volumes of patient data to provide actionable insights. Advancements in Genomics: The increasing availability of genomic data and advances in sequencing technologies have made it possible to develop software that can analyze genetic information and predict disease risks, treatment responses, and health outcomes. Growing Focus on Preventive Healthcare: There is a shift from reactive to proactive healthcare, where precision medicine plays a crucial role in early diagnosis and prevention of diseases. Government Initiatives and Funding: Initiatives like the National Institutes of Health (NIH)'s All of Us program are encouraging the use of precision medicine approaches, which in turn drives demand for relevant software. 📚𝐑𝐞𝐩𝐨𝐫𝐭 𝐅𝐨𝐜𝐮𝐬𝐞𝐝 𝐎𝐧 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:👇 2bPrecise APERIO APERIO BioFortis, a Q² Solutions Company CereHealth Corp. Cohesic Inc Concert Genetics Connexis Deontics Ltd Elucidata Euformatics GenomOncology Health Care Systems, Inc. HealthCare Software Healthcore Hermes Medical Solutions i2b2 tranSMART Foundation Ibex Medical Analytics Idoven Igentify Imagene AI Invivoscribe Jiangsu Superbio Biomedical Co., Ltd. Labvantage - Biomax GmbH LEVY Health LifeOmic Limbic Medlogix Mint Medical, a Brainlab company Neuroventis (Helpilepsy & MigraineManager) Pangaea Data PathAI #Intellectualmarketinsightresearch #Marketresearchreports #Size #Share #Trends #Growth #Opportunity #Outlook #Forecast #Covid19 #Segments #KeyPlayers #RegionsOutlook #GrowthPotential #PriceTrends #CompetitiveMarket #Forecast #2022o2028

𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆: 𝗛𝗮𝗿𝗻𝗲𝘀𝘀𝗶𝗻𝗴 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗕𝗲𝘁𝘁𝗲𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗚𝗲𝘁 𝗣𝗗𝗙 𝗦𝗮𝗺𝗽𝗹𝗲: https://lnkd.in/dJCBK23C 𝗨𝗻𝗹𝗼𝗰𝗸 𝗮 𝘄𝗼𝗿𝗹𝗱 𝗼𝗳 𝗲𝘅𝗽𝗲𝗿𝘁 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝘄𝗶𝘁𝗵 𝗼𝘂𝗿 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗣𝗗𝗙 𝘀𝗮𝗺𝗽𝗹𝗲—𝗲𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲𝗹𝘆 𝗳𝗼𝗿 𝗰𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗲 𝗲𝗺𝗮𝗶𝗹 𝗵𝗼𝗹𝗱𝗲𝗿𝘀. 📧 The field of drug discovery is on the brink of transformation, driven by breakthroughs in technology and a deeper understanding of human biology. Advances in artificial intelligence, machine learning, and bioinformatics are accelerating the discovery process, reducing time and cost to bring life-saving medications to patients. As we harness these powerful tools, the path to targeted, effective treatments has never been clearer, promising a future where we can combat complex diseases more efficiently than ever. Precision medicine is also reshaping drug discovery by enabling researchers to develop therapies tailored to individual genetic profiles. This approach is not only enhancing drug efficacy but also reducing the risk of adverse effects, making treatment safer and more effective. With the integration of genomics, data analytics, and biotechnology, the next generation of drugs has the potential to revolutionize patient care on a global scale The future of drug discovery will rely heavily on collaboration between pharmaceutical companies, tech innovators, and healthcare providers. By working together, these industries can overcome the challenges of complex diseases, ultimately improving patient outcomes. As we look ahead, the commitment to innovation and shared knowledge will be essential in creating a healthier, more hopeful future. #DrugDiscovery #HealthcareInnovation #AIinMedicine #PrecisionMedicine #Pharmaceuticals #FutureOfHealth #Biotech #LifeSciences #InnovationInHealthcare #ClinicalResearch

Drug Discovery Informatics Market Latest Sales Figure Signals More Opportunities Ahead The Drug Discovery Informatics market focuses on the use of informatics #technologies and #software solutions to accelerate the #drugdiscovery and #development process. This field leverages #computationalmethods, #dataanalytics, and #artificialintelligence (AI) to optimize various stages of drug discovery. Chemoinformatics and Bioinformatics: These disciplines involve the use of computational tools to analyze #chemical and #biologicaldata. Chemoinformatics techniques are used for virtual screening of compound #libraries, #structureactivity relationship (SAR) analysis, and predictive modeling of molecular properties. Bioinformatics plays a crucial role in #genomics, #proteomics, and systems biology to identify potential drug targets and understand disease mechanisms. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/d4ZBC2e7 By Type: Sequencing and Target Data Analysis Docking Molecular Modelling Library & Database Preparation Other functions By Application Drug Discovery Drug Development Companies Profiles in the Report: Jubilant Life Sciences Limited (India), Charles River Laboratories (US), IBM (US), Clarivate Analytics (US), Eurofins Scientific (Germany), Thermo Fisher Scientific (US), Accenture PLC (Ireland), PerkinElmer Inc (US), Charles River Laboratories International (US), Schrödingerödinger, Inc. (US), Albany Molecular Research (US), Certara (US), Evotec AG (Germany), Dassault Systèmes Systèmes (Germany), Infosys Limited (India), Collaborative Drug Discovery (CDD), GVK Biosciences (India), Open Eye Scientific (US), Novo Informatics (India), Selvita (Poland), Cognizant (US), Scilligence (US), WuXi AppTec (China), Asteris, IO Informatics (US), Domainex (UK). #𝒎𝒂𝒓𝒌𝒆𝒕𝒔𝒊𝒛𝒆 #𝒎𝒂𝒓𝒌𝒆𝒕𝒕𝒓𝒆𝒏𝒅𝒔 #𝒎𝒂𝒓𝒌𝒆𝒕𝒇𝒐𝒓𝒆𝒄𝒂𝒔𝒕 #𝒎𝒂𝒓𝒌𝒆𝒕𝒂𝒏𝒂𝒍𝒚𝒔𝒊𝒔 #technologies and #software , #drugdiscovery and #development #computationalmethods, #dataanalytics, and #artificialintelligence

𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐢𝐧 𝐈𝐕𝐃 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬, 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐂𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐟𝐨𝐫 𝐈𝐧 𝐕𝐢𝐭𝐫𝐨 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gJwdGpYH The Bioinformatics in In Vitro Diagnostics (IVD) Testing market represents a pivotal intersection between the fields of bioinformatics and medical diagnostics. It involves the application of computational techniques, data analysis, and informatics tools to interpret biological data generated from in vitro diagnostic tests. This market encompasses a broad range of applications, including genomics, proteomics, metabolomics, and clinical informatics, aimed at improving the accuracy, efficiency, and utility of diagnostic testing in healthcare.   𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gJwdGpYH   #Company Affymetrix ASSURERX HEALTH INC Biodesix, Inc. BioReference Life Technologies, Pathogenica Medtronic   #Type • Hardware • Software   #Application • Cardiovascular Diseases • Chronic Diseases • Diabetes • Cancer • Others #Bioinformatics,#IVDTesting,#InVitroDiagnostics,#Healthcare,#MedicalTechnology,#Genomics,#BioinformaticsAnalysis,#DataAnalysis,#PrecisionMedicine,#HealthTech,#ClinicalInformatics,#GeneticTesting,#DiagnosticTesting,#HealthData,#MedicalResearch

𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐢𝐧 𝐈𝐕𝐃 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬, 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐂𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐟𝐨𝐫 𝐈𝐧 𝐕𝐢𝐭𝐫𝐨 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gJwdGpYH The Bioinformatics in In Vitro Diagnostics (IVD) Testing market represents a pivotal intersection between the fields of bioinformatics and medical diagnostics. It involves the application of computational techniques, data analysis, and informatics tools to interpret biological data generated from in vitro diagnostic tests. This market encompasses a broad range of applications, including genomics, proteomics, metabolomics, and clinical informatics, aimed at improving the accuracy, efficiency, and utility of diagnostic testing in healthcare.   𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gJwdGpYH   #Company Affymetrix ASSURERX HEALTH INC Biodesix, Inc. BioReference Life Technologies, Pathogenica Medtronic   #Type • Hardware • Software   #Application • Cardiovascular Diseases • Chronic Diseases • Diabetes • Cancer • Others #Bioinformatics,#IVDTesting,#InVitroDiagnostics,#Healthcare,#MedicalTechnology,#Genomics,#BioinformaticsAnalysis,#DataAnalysis,#PrecisionMedicine,#HealthTech,#ClinicalInformatics,#GeneticTesting,#DiagnosticTesting,#HealthData,#MedicalResearch

𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 - 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐇𝐮𝐛 The bioinformatics services market is expected to grow to between $8.8 billion and $12.71 billion by 2031–2033 👉 ➡️ 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑺𝒂𝒎𝒑𝒍𝒆 𝑹𝒆𝒑𝒐𝒓𝒕 https://lnkd.in/dW-w4RYW #Bioinformatics, as associated with genetics and genomics, is a scientific subdiscipline that involves using computer technology to collect, store, analyze and disseminate biological data and information, such as #DNA and amino acid sequences or observations about those sequences. Bioinformatics services are critical in managing, analyzing, and interpreting vast amounts of biological data generated from genomics, proteomics, and other high-throughput experiments. These services leverage computational tools and algorithms to transform raw biological data into meaningful insights, enabling researchers to understand complex biological systems and make informed decisions. With the exponential growth of data from next-generation sequencing (NGS), bioinformatics services help streamline data processing, ensuring accuracy and efficiency in genomic analysis. 👉 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨 https://lnkd.in/danwfbTC One of the key areas where bioinformatics services are making an impact is drug discovery. By analyzing genetic data, bioinformatics can identify biomarkers and molecular targets that are essential for developing new therapeutics. This allows pharmaceutical companies to design more targeted drugs, improving the chances of successful treatments. In personalized medicine, bioinformatics plays a vital role in tailoring treatments to individual patients based on their genetic makeup, helping healthcare providers develop more precise and effective interventions. 🅺🅴🆈 🅼🅰🆁🅺🅴🆃 🅿🅻🅰🆈🅴🆁🆂- Siemens Healthineers | Stryker | Beckton | GE HealthCare | Teva Pharmaceuticals | Viatris | Ramsay Health Care | Labcorp | Baxter Pharmacy | Boston Scientific | Regeneron | #bioinformatics #genomicanalysis #computationalbiology #bigdata #biotech #drugdiscovery #personalizedmedicine #genomics #biologicaldata #nextgensequencing

IndustryARC™ updated the market research study on “𝐂𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 & 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭” Forecast (2024-2032) 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨👉🏿 https://lnkd.in/gyVUgZFA 𝐇𝐞𝐫𝐞 𝐚𝐫𝐞 𝐬𝐨𝐦𝐞 𝐤𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 & 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 Computational Medicine & Drug Discovery Software is a new field dedicated to learning more about the processes, diagnosis, and treatment of human disease. The process of discovering novel medicines is known as drug discovery. Computational medicine also aids in the detection of genetic flaws and as a result, aids in the prediction of disease causation. Protein-protein interactions as well as protein-ligand interactions are realized using computational medicine & drug discovery software, making it easier to catch the drug target. Increasing government and private sector R&D investments, rising trends in personalized medication consumption, and advancements in information technology, as well as the advent of fast and dependable computing technologies is set to drive its Computational Medicine & Drug Discovery Software industry. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭👉🏿  https://lnkd.in/gvJwWMgK 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Schrödinger., Certara, Chemical Computing Group, Simulations Plus, Inc., Dassault Systèmes, Cresset, Genedata, Compugen Inc #ComputationalMedicine #DrugDiscovery #BiotechSoftware #Pharmaceuticals #Bioinformatics #ComputationalBiology #MolecularModeling #AIinHealthcare #PrecisionMedicine #InSilicoResearch #PharmaTech #MedicinalChemistry #VirtualScreening #DrugDevelopment #Biopharma

𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 - 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐇𝐮𝐛 The bioinformatics services market is expected to grow to between $8.8 billion and $12.71 billion by 2031–2033 👉 ➡️ 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑺𝒂𝒎𝒑𝒍𝒆 𝑹𝒆𝒑𝒐𝒓𝒕 https://lnkd.in/gmmhdW94 #Bioinformatics, as associated with genetics and genomics, is a scientific subdiscipline that involves using computer technology to collect, store, analyze and disseminate biological data and information, such as #DNA and amino acid sequences or observations about those sequences. Bioinformatics services are critical in managing, analyzing, and interpreting vast amounts of biological data generated from genomics, proteomics, and other high-throughput experiments. These services leverage computational tools and algorithms to transform raw biological data into meaningful insights, enabling researchers to understand complex biological systems and make informed decisions. With the exponential growth of data from next-generation sequencing (NGS), bioinformatics services help streamline data processing, ensuring accuracy and efficiency in genomic analysis. 👉 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨 https://lnkd.in/g_9T8rMs One of the key areas where bioinformatics services are making an impact is drug discovery. By analyzing genetic data, bioinformatics can identify biomarkers and molecular targets that are essential for developing new therapeutics. This allows pharmaceutical companies to design more targeted drugs, improving the chances of successful treatments. In personalized medicine, bioinformatics plays a vital role in tailoring treatments to individual patients based on their genetic makeup, helping healthcare providers develop more precise and effective interventions. Keyplayers - Siemens Healthineers | Stryker | Beckton | GE HealthCare | Teva Pharmaceuticals | Viatris | Ramsay Health Care | Labcorp | Baxter Pharmacy | Boston Scientific | Regeneron | #bioinformatics #genomicanalysis #computationalbiology #bigdata #biotech #drugdiscovery #personalizedmedicine #genomics #biologicaldata #nextgensequencing

𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟑𝟒 ▶𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/ddGtQdtv The Precision Medicine Software Market is projected to grow from USD 1.3 billion in 2021 to USD 4.1 billion by 2031, achieving a CAGR of 11.7% over this period. Precision medicine, also known as "personalized medicine," is an advanced approach to disease prevention and treatment that considers individual genetic makeup and unique traits. Precision medicine software, which includes platforms, data-sharing networks, clinical decision support software, and AI-enabled tools, provides integrated data and insights to enhance precision medicine programs. The market's growth is driven by increased government funding for precision medicine initiatives, collaborations between pharmaceutical and software companies, the entry of new players, VC funding, and a rising number of cancer patients. Additionally, the integration of cloud-based solutions and the application of Artificial Intelligence in precision medicine offer significant growth opportunities for market players. 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: ▶𝐁𝐲 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐨𝐝𝐞: On-Premise, Cloud-Based. ▶𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Oncology, Pharmacogenomics, Rare Diseases, Others. ▶𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: Healthcare Providers, Research Centers & Government Institutes, Pharmaceutical & Biotechnology Companies. ▶𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA). 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐯𝐞𝐫𝐞𝐝:          Synapse, Allscripts Healthcare, LLC, ROCHE LEON HOLDINGS, Fabric Genomics, SOPHiA GENETICS, Pierian, QIAGEN, Human Longevity, Inc., Roper Technologies, Inc. #PrecisionMedicine #PersonalizedHealthcare #DigitalHealth #HealthTech #MedicalSoftware #Genomics #Bioinformatics #AIinHealthcare #EHR #HealthInnovation #BigData #HealthcareIT #PatientCare #HealthData #MedicalTechnology #ClinicalResearch #PredictiveAnalytics #GenomicMedicine #HealthcareAI #FutureOfMedicine

🌟 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐰𝐢𝐭𝐡 𝐂𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 & 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞 🌟 - IndustryARC™ 𝐂𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 & 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 Size is forecast to reach $ 1183.1 Million by 2030, at a CAGR of 3.30% during forecast period 2024-2030. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 : @ https://lnkd.in/gM2UsW2g 𝐀𝐈 𝐚𝐧𝐝 𝐌𝐚𝐜𝐡𝐢𝐧𝐞 𝐋𝐞𝐚𝐫𝐧𝐢𝐧𝐠 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐨𝐧: The incorporation of AI and machine learning algorithms is revolutionizing drug discovery and computational medicine. These technologies enhance the ability to predict molecular interactions 𝐈𝐧 𝐒𝐢𝐥𝐢𝐜𝐨 𝐓𝐫𝐢𝐚𝐥𝐬 𝐚𝐧𝐝 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐰𝐢𝐧𝐬: In silico trials, which use computer simulations to model the effects of drugs and treatments, are becoming increasingly prevalent. The concept of digital twins, where virtual models of patients are created to simulate and predict individual responses to treatments, is also gaining traction. 𝐂𝐥𝐨𝐮𝐝 𝐂𝐨𝐦𝐩𝐮𝐭𝐢𝐧𝐠 𝐚𝐧𝐝 𝐇𝐢𝐠𝐡-𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐂𝐨𝐦𝐩𝐮𝐭𝐢𝐧𝐠 (𝐇𝐏𝐂): The adoption of cloud computing and HPC is enabling the handling of vast datasets and complex computational tasks required in drug discovery. 𝐠𝐞𝐭 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨 : @ https://lnkd.in/gN6esfCy 𝐓𝐨𝐩 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐚𝐫𝐬 : Hologic, Inc.|Genesis Healthcare System|Jazz Pharmaceuticals|Sinobiopharma, Inc. |Incyte|ONO|athenahealth |Octapharma|Ipsen|Dexcom|Watershed|Teleflex|Bio-Rad Laboratories|Exact Sciences |BioMarin Pharmaceutical Inc.|enVista|Royalty Pharma|Seagen|Grünenthal Group|Neurocrine Biosciences|Exelixis|Alnylam Pharmaceuticals|OSI Systems|Chr. Hansen              #DrugDiscovery #ComputationalBiology #Bioinformatics #PharmaTech #MedTech #AIinMedicine #MachineLearning #InSilico #DigitalHealth #Biotech #PersonalizedMedicine #HealthTech #ClinicalTrials #Genomics #MolecularModeling